All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
Phosphodiesterase inhibitors, which include anagrelide, cilostazol, and milrinone, prevent breakdown of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) promoting vasodilation and smooth muscle relaxation. They have also been shown to block intracellular TLR signaling, leading to apoptosis in malignant lymphocytic cells.